Cost Effectiveness of Optifast® LCD As Compared with Liraglutide 3 Mg And “No Intervention” In Switzerland
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.885
https://www.valueinhealthjournal.com/article/S1098-3015(17)31219-6/fulltext
Title :
Cost Effectiveness of Optifast® LCD As Compared with Liraglutide 3 Mg And “No Intervention” In Switzerland
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31219-6&doi=10.1016/j.jval.2017.08.885
First page :
A554
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
841